Get started
Author

Jacob Fredsøe

Observed names: Fredsøe, Jacob, Fredsøe, Jacob Christian, J. Fredsøe, Jacob Christian Fredsøe, Jacob Fredsoe, Jacob H. Fredsøe
ORCID: 0000-0002-7319-2467
Observed ORCID: 0000-0002-7319-2467
OpenAlex ID: A5032699327
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine
2017 · Jacob Fredsøe, Anne K.I. Rasmussen, et al. · European Urology Focus · 120
PDF
68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
2020 · Søren Klingenberg, Mads R. Jochumsen, et al. · Journal of Nuclear Medicine · 104
PDF
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors
2021 · Line B Andersen, Maibritt Nørgaard, et al. · The Journal of Pathology · 84
Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling
2022 · Paul Vinu Salachan, Martin Rasmussen, et al. · Genome Medicine · 59
PDF
DNA Hairpins as Temperature Switches, Thermometers and Ionic Detectors
2013 · Anette Jonstrup, Jacob Fredsøe, et al. · Sensors · 59
DNA Topoisomerases Maintain Promoters in a State Competent for Transcriptional Activation in Saccharomyces cerevisiae
2012 · Jakob Madsen Pedersen, Jacob Fredsoe, et al. · PLoS Genetics · 51
PDF
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
2022 · Emma Bollmann Hansen, Jacob Fredsøe, et al. · Genome Medicine · 50
PDF
A five‐microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell‐free urine
2019 · Jacob Fredsøe, Anne K.I. Rasmussen, et al. · International Journal of Cancer · 44
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
2019 · Marianne T. Bjerre, Siri H. Strand, et al. · International Journal of Molecular Sciences · 42
PDF
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer
2023 · Maibritt Nørgaard, Marianne T Bjerre, et al. · Clinical Chemistry · 41
PDF
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer
2022 · Malene Blond Ipsen, Ea Marie Givskov Sørensen, et al. · Oncogene · 35
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
2020 · Marianne Trier Bjerre, Maibritt Nørgaard, et al. · Cells · 35
PDF
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
2018 · L. Schmidt, J. Fredsøe, et al. · Annals of Oncology · 35
PDF
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer
2021 · Anson Ku, Jacob Fredsøe, et al. · Frontiers in Oncology · 34
PDF
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
2020 · Jacob Fredsøe, Anne K. I. Rasmussen, et al. · Diagnostics · 32
PDF
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine
2019 · Jacob Fredsøe, Anne K I Rasmussen, et al. · Clinical Chemistry · 28
Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells
2019 · Emma B. Laursen, Jacob Fredsøe, et al. · American Journal Of Pathology · 19
PDF
Top2 and Sgs1-Top3 Act Redundantly to Ensure rDNA Replication Termination
2015 · Kamilla Mundbjerg, Signe W. Jørgensen, et al. · PLoS Genetics · 17
DNA Topoisomerases Are Required for Preinitiation Complex Assembly during GAL Gene Activation
2015 · Morten Roedgaard, Jacob Fredsoe, et al. · PLoS ONE · 15
PDF
Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population
2023 · Jacob Fredsøe, Mads Sandahl, et al. · European Urology Oncology · 14
PDF
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk
2024 · Martin Rasmussen, Jacob Fredsøe, et al. · npj Precision Oncology · 13
PDF
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
2020 · Jacob Fredsøe, Jan Koetsenruyter, et al. · PLoS Medicine · 12
PDF
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach
2022 · Bettina Wulff Risør, Nasrin Tayyari Dehbarez, et al. · Applied Health Economics and Health Policy · 11
PDF
Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT
2022 · Søren Klingenberg, Jacob Fredsøe, et al. · Acta Oncologica · 9
PDF
A genetic risk assessment for prostate cancer influences patients’ risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice
2020 · Jacob Fredsøe, Pia Kirkegaard, et al. · BJGP Open · 7
PDF
Works count: 71
Citation count: 998
H-index: 17
I10-index: 23
Year
Topic
Type